Skip to content

Data Migration and Mapping Functions

Data Migration and Mapping Functions

Medical software does not have a good reputation for user experience and intuitive design. It can seem like a full-time job just learning how to use these software solutions.  In fact, according to a study from Stanford Medicine, 74% of doctors responded that their EMR increased the number of hours they work every day and 71% say their EMRs lead to physician burnout.  With this information, coupled with the increase use of telehealth (another software to learn), it’s no wonder that providers and their staff are looking for alternatives to simplify their clinical software, while not sacrificing the quality of patient care.

At Arfinn Med, we believe that your clinical software should be easy to use, fast and allow you to spend more time focusing on patient care rather than data entry. This focus on intuitive software design is why we are the leading EMR for alternative medicine clinics including practices focusing on cannabis and cannabinoid medicine.  Despite this, we still hear from providers who wish to switch to our platform that they are concerned about migrating data from paper charts or from another system.  We at Arfinn Med decided to address this concern.

We are proud to release our new secure data mapping software and a team of employees to focus on data migration.  This new system will allow us to speed up the time it takes to switch patient data, while also not interrupting your current practice workflows. You will also be assigned a team member from Arfinn to help with extraction of any additional data such as attached files, appointments and/or consents.

If you are interested in learning more about our data migration protocol, please reach out to us at info@arfinnmed.com.

Sincerely from quarantine,

The Arfinn Med Team

Stories you may be interested in

Survey of oncologists finds knowledge gap on medical marijuana

As more states legalize medical marijuana, two key groups — researchers whose job is it to understand its benefits and drawbacks, and physicians charged with advising potential users — are struggling to catch up with policymakers. Ilana Braun, an assistant professor of psychiatry at Harvard Medical School and chief of the division of adult psychosocial…
Read More

You Can Get A Master’s In Medical Cannabis In Maryland

Summer Kriegshauser is one of 150 students in the inaugural class of the University of Maryland, Baltimore’s Master of Science in Medical Cannabis Science and Therapeutics, the first graduate program of its type in the country. This will be Kriegshauser’s second master’s degree and she hopes it will offer her a chance to change careers. “I…
Read More

New Feature: Calendar Integration

At Arfinn Med, we’re excited to announce the third feature update to join automated text messaging and note templating: calendar integration. With this addition, physicians can now integrate their Google Calendar or Calendy account. The implementation of calendar integration rounds out the Arfinn Med portal, making it a physician’s one-stop-shop EMR tool. How It Works…
Read More

Finally, Georgia can grow medical marijuana. Here’s what you need to know.

Four years ago, Governor Nathan Deal signed into law Haleigh’s Hope Act, which made low-THC cannabis oil legal to use by those with certain medical conditions. However, as it was still against the law to buy or grow marijuana in the state, it was virtually impossible to obtain the oil in Georgia. Patients were forced…
Read More

Arfinn Med March Updates

We are very happy to announce the release of several new functions within the Arfinn Med Platform.  Those include: * Text message updates from patients regarding their treatments * Templating for exam notes  * Updated analytics and dosing reports * Google calendar and Calendly integrations to schedule appointments. Please view the video below for more…
Read More

Are You Prepared For Questions About Medical Cannabis?

With over 85% of Americans supporting legalizing medical cannabis, it’s inevitable that patients will begin asking their primary care doctors about its use and overall efficacy. Doctors and other medical professionals will be called upon to be ‘sense-makers’ for a treatment they never studied in medical school and have limited available research to draw upon. …
Read More

Leave a Comment

You must be logged in to post a comment.